Monascus rice powder co-supplemented with coenzyme Q 10 improves serum lipids and LDL-lag time on hypercholesterolemia subjects. Shih-Wen Hsu 1#, Yi-Ting.

Slides:



Advertisements
Similar presentations
Rice Bran Pennington Biomedical Research Center Division of Education Heli J. Roy PhD Shanna Lundy, BS Phillip Brantley, PhD, Director.
Advertisements

Lipid Metabolism 3: Cholesterol biosynthesis, lipoprotein metabolism, steroid and eicosanoid synthesis Bioc 460 Spring Lecture 37 (Miesfeld) Steroids.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Free radicals and antioxidants in health and disease
GNC Mega Men: Maximum Nutrition GNC Mega Men: Maximum Nutrition Dietary supplement “Mega Men® Maximum Nutrition is more than just a multivitamin, it features.
Plant Sterols Roles in Margarines Pennington Biomedical Research Center Division of Education Heli J. Roy PhD Shanna Lundy, BS Phillip Brantley, PhD, Director.
A Natural Healthcare Company Pharmanex, Inc. Selected by Nature... Proven by Science.
RED WINE AND THE EFFECTS ON LDL CHOLESTEROL By: Krista Howieson.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
 High density lipoproteins (HDL) protect against cardiovascular disease  A novel mechanism for raising HDL levels is to inhibit a protein known as CETP.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
International Workshop on LHC, Astrophysics, Medical and Environmental Physics. Shkodra (Albania), 6-8 October OLIVE OIL COMPOSITION AND HEALTH BENEFITS.
Hyperlipidemia John Baer.
By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University By Hussam A.S. Murad.
Probiotics containing complex vegetable fermented fibers (CVFF) enhanced human intestinal microflora. Hsin-Ju Chou 12, Yasuhiro Nakayama 2, Ya-Yuan Chuang.
BackgroundBackground HDL-C levels are inversely related to CV event rates. HDL-C levels are inversely related to CV event rates. Torcetrapib, a cholesteryl.
Taurine Supplementation Improves the Utilization of Sulfur-Containing Amino Acids in Consecutive Alcohol Administration Rats Hui-Ting Yang 1, Ching-Chien.
Taipei Medical University. Adolescents with Higher Althernate Healthy Eating Index For Taiwan (AHEI-T) Scores Have Lower Blood Lipid Level De-Zhi Weng,
Copyright® Raisio A plant stanol yogurt drink alone or combined with a low-dose statin lowers serum triacylglycerol and non-HDL cholesterol.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
大豆蛋白質對慢性腎衰竭患者血壓、血脂與腎功能的影響 Hyperlipidemic factors contribute to the high cardiovascular risk in hemodialysis patients and may accelerate the progression.
Bioavailibility and Effect on Lipid Metabolism of Crude β- Carotene Extract from Sweet Potato Leaves and Synthetic β- Carotene in Rats Fed Different High.
Cholesterol metabolism: INTRODUCTION  Cholesterol is a sterol, present in cell membrane, brain and lipoprotein  It is a precursor for all steroids 
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
Niacin (Nicotinic Acid) C 6 H 5 NO 2. Nicotinamide- no reduction in blood cholesterol Inositol Hexaniacinate- not much research, unlikely that it lowers.
Copyright® Raisio Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment.
How We Obtain Sufficient Coenzyme Q Benjamin Dahl Beloit College, Beloit, Wisconsin Abstract Avoiding Coenzyme Q (CoQ) deficiency is important because.
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.
B-1 Pravastatin-Aspirin Combination René Belder, M.D. Executive Director Clinical Design and Evaluation, Metabolics Pharmaceutical Research Institute Bristol-Myers.
Tetraterpenoid البرفسور الدكتور طلال ابورجيع. Tetraterpenoids CAROTENOIDS Among this important group, the numerous compounds consist of C40 chains with.
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Flaxseed in Pediatric Hyperlipidemia Wong H, Chahal N, Manlhiot C, Niedra E, McCrindle.
Follicle-Stimulating Hormone Induces Postmenopausal Dyslipidemia Through Inhibiting Hepatic Cholesterol Metabolism J Clin Endocrinol Metab 101: 254–263,
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans Bonnie Ky, MD,* Anne Burke, MD,* Sotirios Tsimikas,
1 A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia Diabetes Care 28:1547–1554,
Liver cholesterol (mg/g)
Cholesterol metabolism
Effect of fish oil supplementation on serum triglycerides, LDL cholesterol and LDL subfractions in hypertriglyceridemic adults  B. Oelrich, A. Dewell,
The Lipids: Triglycerides, Phospholipids, and Sterols
The Plasma Concentrations of Atorvastatin and its Active Metabolites in Relation to the Dose in Stable Coronary Artery Disease Patients at a Tertiary Referral.
Cardiovascular Disease
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
Drugs for Lipid Disorders
Rambam health care campus, Haifa, Israel
Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.
Anti-Hypercholesterolemic Agents
Copyright © 2001 American Medical Association. All rights reserved.
Green Tea and Lipid Oxidation
Formative Test.
Tirawanchai N , Somkasetrin A , Kengkoom K, Ampawong S
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Lipoprotein(a), Cardiovascular Disease, and Contemporary Management
Anti-Hypercholesterolemic Agents
Cholesterol Synthesis, Transport, & Excretion
Oxford Niacin Trial.
Biosynthesis and Metabolism of Cholesterol
Weight Management the natural way
RAYDEL® Policosanol 10 Healthy Cholesterol Management since 1986
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY.
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Section 7: Aggressive vs moderate approach to lipid lowering
A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical.
James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D. 
LRC-CPPT and MRFIT Content Points:
Section IV: The interaction of the RAS and lipids
Major classes of drugs to reduce lipids
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
Presentation transcript:

Monascus rice powder co-supplemented with coenzyme Q 10 improves serum lipids and LDL-lag time on hypercholesterolemia subjects. Shih-Wen Hsu 1#, Yi-Ting Lin 1, Hui-Ting Yang 2, Ching-Chien Chang 1, Ming-Jer Shieh 1, and Shih-Yi Huang 1 * 1 School of Nutrition and Health Sciences,Taipei Medical University,Taipei, Taiwan. 2 Department of Medical Nutrition, I-Shou University, Kaohsiung, Taiwan. 37 subjects were recruited and were randomly divided into three groups such as Monascus rice powder 250 mg (M), equivalent to monacolins 10 mg; Monascus rice powder 250 mg plus CoQ10 15 mg (MQ), and Monascus rice powder 500 mg plus CoQ10 30 mg (HMQ) by different doses supplementation. The supplementations administrated for 6 weeks, blood samples were collected every two weeks for cholesterol and low density lipoprotein (LDL) lag time determination. The final results were presented as mean ± SD. Student’s t test was used for statistically analysis. Abstract Subjects and Methods Recent studies showed a possibly interruption of monacolins, byproducts of Monascus rice powder, on coenzyme Q10 biosynthesis. Thus, a clinical trial was conducted to investigate lipid-lowering and antioxidative effects of combined red yeast rice extract and coenzyme Q10 (CoQ10) supplementation on hypercholesterolemia subjects. 37 subjects were recruited and were randomly divided into three groups such as Monascus rice powder 250 mg (M), equivalent to monacolins 6 mg; Monascus rice powder 250 mg plus CoQ10 15 mg (MQ), and Monascus rice powder 500 mg plus CoQ10 30 mg (HMQ) by different doses supplementation. The supplementations administrated for 6 weeks, blood samples were collected every two weeks for cholesterol and low density lipoprotein (LDL) lag time determination. Results showed that all of the groups had lower serum total cholesterol (19.6%, 32.7%, and 19.6% decrease from baseline, p<0.05) and LDL cholesterol concentration (28.6%, 42.3%, and 29.0% decrease from baseline, p<0.05) after three weeks of supplementation. Moreover, there were no alterations on high density lipoprotein (HDL) cholesterol level of all subjects. In LDL-lag time, the data displayed a significant slower production of conjugated dienes in all groups after six weeks of supplementation. However, in CoQ10 supplementing groups, the effect sustained after ceasing supplementation for two weeks. The results reconfirmed the lipid-lowering effects of monacolins and 250 mg Monascus rice powder, (equivalent to monacolins 6 mg) supplementation didn’t affect the LDL oxidative process through disruption of CoQ10 metabolism. Furthermore, addition of at least 15 mg CoQ10 could significantly enhance LDL antioxidative capacity in hypercholesterolemia subjects. Results Discussion Recent studies showed the active compound of Monascus rice powder, Monacolin K, could inhibit hydroxymethyl glutaryl coA reductase (HMG CoA reductase) which are the key enzyme of internal cholesterol synthesis in our body. The present results showed that daily intake of 250mg Monascus rice powder (equivalent to 6mg of monacolins) significantly lowered serum total and LDL cholesterol concentration ( p<0.05) and remained normal after three weeks of supplementation. Besides, there were no alterations on high density lipoprotein (HDL) cholesterol level of all subjects. In LDL-lag time, the data displayed a significant delayed production of conjugated dienes in all groups after six weeks of Monascus rice powder supplementation. However, in CoQ 10 supplementing groups, the effect sustained after empty intervention for two weeks. The results reconfirmed the lipid-lowering effects of Monascus rice powder and the supplementation didn’t accelerate LDL oxidation through disruption of CoQ 10 metabolism. Furthermore, addition of at least 15 mg CoQ 10 could significantly enhance LDL antioxidative capacity in hypercholesterolemia subjects. Fig. (A) LDL lag time of different groups, Fig. (B) Cholesterol concentrations of different groups, Fig. (C) LDL concentrations of different groups, Fig. (D) HDL concentrations of different groups, "a, b, c“ represented significant differences with different time periods ; ”*,**” represented significant differences within groups, p<0.05. Daily supplemented with 250 mg of Monascus rice powder and 15 mg of CoQ 10 for six weeks could not only significantly regulate serum total and LDL cholesterol concentration in subjects with hypercholesterolemia but also delayed LDL oxidation. The combination might assist to decrease the risk of atherosclerosis progress and to prevent the incidence of cardiovascular disease. Conclusion